STOCK TITAN

US Physical Therapy (USPH) Insider Plans Sale of 700 Shares via Schwab

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

US Physical Therapy, Inc. (USPH) filed a Form 144 proposing the sale of 700 shares of common stock through Charles Schwab & Co., Inc. The filing lists an approximate sale date of 08/25/2025 and reports an aggregate market value of $60,119. It shows total shares outstanding of 15,204,119, indicating the proposed sale represents a very small fraction of the companys outstanding stock. The shares were acquired on 01/01/2025 as employee equity compensation (1,208 shares reported acquired). The filer reports no sales in the past three months.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Small insider sale notice; amount is immaterial relative to outstanding shares.

The Form 144 notifies the market of a proposed sale of 700 shares valued at $60,119 via Charles Schwab with an approximate trade date of 08/25/2025. Against 15.2 million shares outstanding, the position is negligible, suggesting limited market impact. The securities were acquired as employee equity compensation on 01/01/2025. No prior sales in the past three months are reported, which reduces concerns about accelerated insider liquidation.

TL;DR: Filing appears routine and compliant; standard attestation included.

The notice includes the required attestation that the seller is not aware of undisclosed material adverse information and references the Rule 10b5-1 plan language. Broker details and acquisition method are disclosed, and the filing indicates no recent sales to aggregate. From a compliance perspective, the form contains the standard disclosures expected for an insider sale arising from equity compensation.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does USPH's Form 144 disclose about the planned insider sale?

The Form 144 discloses a proposed sale of 700 shares of USPH common stock through Charles Schwab with an approximate sale date of 08/25/2025 and an aggregate market value of $60,119.

How large is the proposed sale relative to USPH outstanding shares?

The filing reports 15,204,119 shares outstanding; the proposed sale of 700 shares represents approximately 0.0046% of outstanding shares.

When and how were the shares being sold acquired?

The shares were acquired on 01/01/2025 as employee equity compensation, with 1,208 shares reported acquired on that date.

Did the filer report any sales of USPH securities in the prior three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Does the Form 144 include standard attestations about material information?

Yes. The filer represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed and references Rule 10b5-1 trading plan language.
U S Physical Therapy

NYSE:USPH

USPH Rankings

USPH Latest News

USPH Latest SEC Filings

USPH Stock Data

1.33B
14.90M
1.94%
105.69%
4.3%
Medical Care Facilities
Services-health Services
Link
United States
HOUSTON